CA
NZ
UK
AU
IND
US
Precision BioSciences has taken another operational step forward in the development of PBGENE-HBV, its investigational gene-editing therapy for chronic hepatitis B. The company announced Clinical Trial Application approval to expand the global ELIMINATE-B study into France and Romania.
Arbutus Biopharma has received an important regulatory milestone after the U.S. Food and Drug Administration granted Fast Track designation to imdusiran for chronic hepatitis B.
Allogene Therapeutics has announced a substantial equity financing aimed at reinforcing its balance sheet and supporting continued advancement of its allogeneic CAR-T cell therapy pipeline.
Medicus Pharma is set to present new Phase 1 clinical data at AACE 2026 for Teverelix, its long-acting GnRH antagonist candidate. The update is notable because it addresses several critical considerations for hormone-modulating therapies: efficacy consistency, reversibility, dosing convenience, bone health, and tolerability.
Shares of Taysha Gene Therapies climbed 15 per cent on Wednesday after Canaccord Genuity raised its price target on the stock to $17 from $14, a move that reflects mounting analyst confidence in the Dallas-based company's clinical trajectory and the broadening commercial potential of …
There is a well-worn chapter in the history of capital markets that repeats with reliable regularity: a company with a fading core business discovers the hottest theme of the moment and attempts to reinvent itself overnight. In late 2017, it was blockchain. In 2026, …
US import prices rose 0.8% in March 2026, missing forecasts, while export prices surged 5.6% annually, the strongest gain since November 2022. Analyse the macroeconomic implications for inflation, Federal Reserve policy, and capital markets.Key HighlightsUS import prices rose 0.8% month-over-month in March 2026, missing …
Shares of Robinhood Markets and Webull rose sharply in premarket trading on Wednesday after the Securities and Exchange Commission approved a plan by the Financial Industry Regulatory Authority to dismantle the Pattern Day Trader rule — a two-decade-old restriction that has long been a …
When the purchasing power of currency erodes, tangible assets with intrinsic value have historically preserved — and often grown — wealth. Here is everything you need to know about hard assets as an inflation hedge.What are hard assets?Hard assets are tangible, physical resources with …
Meta Platforms (NASDAQ:META) and Broadcom (NASDAQ:AVGO) announced on Tuesday a strategic, multi-year agreement that significantly deepens their existing collaboration on custom artificial intelligence silicon, extending a shared roadmap through 2029. The deal signals a structural shift in how the world's largest social media operator …
Please wait processing your request...